Research ArticleClinical Investigation
Tumor Dose–Response Relationship of [131I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [124I]MIBG PET
Alexandros Moraitis, Andre Prochnow, Thorsten Dirk Poeppel, Jochen Schmitz, Christina Laschinsky, Ken Herrmann, Andreas Bockisch, Pedro Fragoso Costa, David Kersting and Walter Jentzen
Journal of Nuclear Medicine April 2025, 66 (4) 641-647; DOI: https://doi.org/10.2967/jnumed.124.269377
Alexandros Moraitis
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany
Andre Prochnow
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany
Thorsten Dirk Poeppel
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany
Jochen Schmitz
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany
Christina Laschinsky
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany
Ken Herrmann
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany
Andreas Bockisch
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany
Pedro Fragoso Costa
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany
David Kersting
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany
Walter Jentzen
1Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and
2German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 4
April 1, 2025
Tumor Dose–Response Relationship of [131I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [124I]MIBG PET
Alexandros Moraitis, Andre Prochnow, Thorsten Dirk Poeppel, Jochen Schmitz, Christina Laschinsky, Ken Herrmann, Andreas Bockisch, Pedro Fragoso Costa, David Kersting, Walter Jentzen
Journal of Nuclear Medicine Apr 2025, 66 (4) 641-647; DOI: 10.2967/jnumed.124.269377
Tumor Dose–Response Relationship of [131I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [124I]MIBG PET
Alexandros Moraitis, Andre Prochnow, Thorsten Dirk Poeppel, Jochen Schmitz, Christina Laschinsky, Ken Herrmann, Andreas Bockisch, Pedro Fragoso Costa, David Kersting, Walter Jentzen
Journal of Nuclear Medicine Apr 2025, 66 (4) 641-647; DOI: 10.2967/jnumed.124.269377
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.